Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 17, 2015Expert Opinion on Pharmacotherapy

The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBoris HügleGHGerd Horneff

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hügle et al. (2015) studied this question.

synapsesocial.com/papers/6a8309a1a250d11ff44cd0fahttps://doi.org/10.1517/14656566.2016.1133592
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register2015 · 52 citations
  2. 2High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score2011 · 182 citations
  3. 3Effectiveness of First‐Line Treatment With Recombinant Interleukin‐1 Receptor Antagonist in Steroid‐Naive Patients With New‐Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study2013 · 263 citations